How Are Clinical Trials Regulated By The MFDS In South Korea?

Clinical trials in South Korea are regulated by the MFDS through comprehensive guidelines that ensure compliance with Good Clinical Practice (GCP) standards. The MFDS reviews and approves clinical trial applications, monitors trial conduct, and inspects sites for adherence to protocols. It also mandates reporting of adverse events to ensure participant safety and data integrity.

Leave a Reply

You must be logged in to post a comment.